Using a continuous glucose monitor (CGM) with education to improve satisfaction and quality of life for adults with diabetes
Continuous Glucose Monitor (CGM) Discharge Program
This program will try whether providing inpatient diabetes education together with a continuous glucose monitor (CGM) improves satisfaction and quality of life for adults with Type 1 or Type 2 diabetes who use insulin.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 37 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Cedars-Sinai Medical Center Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Trial ID | NCT06965803 on ClinicalTrials.gov |
What this trial studies
This is a single-center observational program at Cedars-Sinai where adults with Type 1 or Type 2 diabetes on insulin who have not used a CGM in the prior six months receive standard inpatient diabetes education and a CGM. Participants complete a satisfaction and quality-of-life survey before and after the intervention to measure changes in patient-reported outcomes. The intervention requires smartphone ownership and English fluency and is limited to patients able to provide informed consent. No randomization or experimental drug/device procedures beyond usual CGM use are described.
Who should consider this trial
Good fit: Adults (18+) with Type 1 or Type 2 diabetes who use insulin, speak English, own a smartphone, are scheduled for standard inpatient diabetes education, have not used a CGM in the past six months, and can provide informed consent.
Not a fit: Pregnant patients, non-English speakers, those who have used a CGM within six months, people not on insulin, or patients without a smartphone are unlikely to be eligible or to benefit from this program.
Why it matters
Potential benefit: If successful, combining education with CGM use could increase user satisfaction and improve daily quality of life for people on insulin.
How similar studies have performed: Previous research has shown that CGM use combined with diabetes education often improves patient satisfaction and glycemic outcomes, so this program builds on established findings in a focused inpatient setting.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * aged 18 or older * diagnosed with Type 1 or Type 2 Diabetes who are on insulin * able to speak and understand English language * scheduled to receive a standard inpatient diabetes education consultation * must not have used CGM in the six months prior to admission * owns a smartphone * demonstrates the ability to follow instructions and be capable of providing informed consent to participate in the program Exclusion Criteria: * those who are known to be pregnant. This is due to complexity of pregnancy-related changes in glucose metabolism and increased skin sensitivity, or changes in skin condition to adhesives and materials used in CGM devices. * non-English speakers. As this is small study to evaluate which method is favorable using a survey only validated in English, enrolling non-English speakers would require additional resources/translations/personnel for evaluation and the education intervention that are not logistically possible right now.
Where this trial is running
Los Angeles, California
- Cedars-Sina Medical Center — Los Angeles, California, United States (Recruiting)
Study contacts
- Study coordinator: Mathew P Monterola, Doctor of Nursing Practice
- Email: Mathew.Monterola@cshs.org
- Phone: 3109677434
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.